NVCT
Nuvectis Pharma·NASDAQ
--
--(--)
--
--(--)
6.20 / 10
Outperform
Fund flow is robust (score 7.77/10) with positive Medium and Extra-large inflows, offsetting negative overall block flows. Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from one analyst, supporting the stock despite technical and fundamental challenges.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-04
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate66.7%
Is money flowing into or out of NVCT?
- NVCT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.20/10 (Outperform).
